Zentralbl Chir 2021; 146(S 01): S73
DOI: 10.1055/s-0041-1733423
Abstracts

V-190 Grading of metastases is a prognostic factor for survival after pulmonary metastasectomy for leiomyosarcoma

Authors

  • T Stork

    1   Ruhrlandklinik, Thoraxchirurgie, Essen, Deutschland

  • B Hegedüs

    1   Ruhrlandklinik, Thoraxchirurgie, Essen, Deutschland

  • S Bauer

    2   Universitätsklinikum Essen, Innere Medizin (Tumorforschung), Essen, Deutschland

  • C Aigner

    1   Ruhrlandklinik, Thoraxchirurgie, Essen, Deutschland

  • S Collaud

    1   Ruhrlandklinik, Thoraxchirurgie, Essen, Deutschland
Weitere Informationen
Auch verfügbar auf
 

Hintergrund

Survival in patients with metastatic leiomyosarcoma is still poor, with 5-year survival of about 20%. Chemotherapeutic options are limited. Pulmonary metastasectomy (PM) is an established treatment option in patients with isolated lung metastases. Here we focused on patients with leiomyosarcoma undergoing PM. Outcome and potential clinical prognostic factors were assessed.



Publikationsverlauf

Artikel online veröffentlicht:
06. September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany